Research programme: Hepatitis B vaccine - Haikou VTI Biological InstituteAlternative Names: Therapeutic HBV vaccine - Haikou VTI
Latest Information Update: 02 May 2014
At a glance
- Originator Haikou VTI Biological Institute
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Hepatitis B
Most Recent Events
- 02 May 2014 Early research in Hepatitis B in China (unspecified route) prior to May 2014